Brought to you by
Untargeted metabolomics is the measure of all metabolites in a system, which is increasingly recognized as a tool for biomarker discovery. Flow injection analysis (FIA)-mass spectrometry (MS) is a valuable platform for untargeted metabolomics, however this technique requires high-resolution MS to resolve complex samples without front-end separation.
We integrated Magnetic Resonance Mass Spectrometry (MRMS) with automated FIA to create a high-throughput metabolomics platform that rapidly acquires large sample sets and identifies metabolites with sub-ppm accuracy. FIA-MRMS requires only five minutes of analysis time per sample and detects thousands of metabolite features with exceptional reproducibility.
This webinar will introduce the FIA-MRMS workflow and present two case studies where it is used: to determine changes in blood plasma metabolites in obese and Type II diabetic mice, and to profile human-induced pluripotent stem cell-derived cardiomyocytes (hPSC-CMs).
Following our interaction with you, Bruker Daltonics and its affiliates within the Bruker group (“Bruker”) would like to be able to stay in contact with you and inform you about the latest technological achievements and upcoming events as well as the products and services offered by Bruker. If you are interested in hearing from us in the future, we will need your consent in accordance with applicable data protection laws to be allowed to engage in marketing activities using your contact information.
If you prefer not to receive promotional e-mails from Bruker in the future, you can unsubscribe at any time here.
Copyright © 2020 Bruker Scientific LLC | 40 Manning Road | Billerica, MA | 01821.
For research use only. Not for use in diagnostic procedures.